A local court on Monday granted bail to chief executive officer (CEO) of the Medley Pharmaceuticals Ltd, the company's whose name surfaced in the sub-standard drugs scam that hit Kashmir last month.
Special public prosecutor Musavir Rafiq Joo, while hearing the case in the TADA court, also the designate court under Drugs and Cosmetic Act, granted bail to Surinder Sharma, CEO of the Medley Pharmaceuticals Ltd, till next hearing.
It was Sharma's first personal appearance before the court. The court will again hear the case in the third week of June. A sub-standard drug came to the fore in the first week of April in the valley when the government-run drug testing labs found 12 samples sub-standard.
Preliminary reports suggest that antibiotic tablets, branded as Maximizin, had "zero per cent" amoxicillin in 625-mg tablets. The drug was supplied to the government hospitals in the state.
However, the Mumbai-based company distanced itself from the scam and claimed its brand name and packaging were misused by a Jammu-based company.
The hospital supply of Maximizin had come through Life Line Pharmaco Surgicals Ltd, a Jammu-based company owned by Amardeep Raina and Ashok Raina. At least 15 people are facing charges in the sub-standard drugs scam. The TADA court ordered the deputy inspector general (DIG) Crime, Jammu, to bring three accused before the court on the next hearing. It also asked inspector general of police, Kashmir, to present four others before the court "through non-bailable warrants".
Meanwhile, advocate Vishal Sharma filed power of attorney on behalf of four accused.